Zynex Inc Stock Investor Sentiment

ZYXI Stock  USD 8.34  0.08  0.97%   
Under 62% of Zynex's investor base is looking to short. The analysis of overall sentiment of trading Zynex Inc stock suggests that many investors are alarmed at this time. Zynex's investing sentiment shows overall attitude of investors towards Zynex Inc.
  

Zynex Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Zynex can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over a month ago at insidermonkey.com         
Zynex, Inc. Q3 2024 Earnings Call Transcript
insidermonkey News
over a month ago at simplywall.st         
Zynex Seems To Use Debt Quite Sensibly
Simply Wall St News at Macroaxis
over a month ago at finance.yahoo.com         
Zynex Third Quarter 2024 Earnings EPS Beats Expectations, Revenues Lag
Yahoo News
over a month ago at gurufocus.com         
Zynex Inc Q3 2024 Earnings Call Highlights Navigating Growth and Challenges
Gurufocus Stories at Macroaxis
over a month ago at investing.com         
Earnings call Zynex reports steady Q3 growth, plans for future expansion
Investing News at Macroaxis
over a month ago at kalkinemedia.com         
Why Did Zynex Receive FDA Clearance for Its New Device?
news
over a month ago at finance.yahoo.com         
Zynex Reports Third Quarter 2024 Financial Results
Yahoo News
over a month ago at seekingalpha.com         
Zynex GAAP EPS of 0.07 beats by 0.01, revenue of 49.97M misses by 0.86M
seekingalpha News
over a month ago at investing.com         
Zynex earnings beat by 0.01, revenue fell short of estimates
Investing News at Macroaxis
over a month ago at finance.yahoo.com         
Zynex Inc. Tops Q3 Earnings Estimates
Yahoo News
over a month ago at zacks.com         
Zynex Inc. Tops Q3 Earnings Estimates
zacks News
over a month ago at thelincolnianonline.com         
Zynex Releases Q4 Earnings Guidance
news
over a month ago at seekingalpha.com         
Zynex Q3 2024 Earnings Preview
seekingalpha News
over a month ago at finance.yahoo.com         
Pain Management Devices Market Report 2024 and Company Benchmarking for Abbott, Medtronic, Zynex Med...
Yahoo News
over a month ago at finance.yahoo.com         
Zynex Sets Third Quarter 2024 Earnings Call
Yahoo News
Far too much social signal, news, headlines, and media speculation about Zynex that are available to investors today. That information is available publicly through Zynex media outlets and privately through word of mouth or via Zynex internal channels. However, regardless of the origin, that massive amount of Zynex data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Zynex news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Zynex relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Zynex's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Zynex alpha.

Zynex Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Disposition of 5250 shares by Daniel Moorhead of Zynex at 7.89 subject to Rule 16b-3
09/05/2024
2
Acquisition by Daniel Moorhead of 5000 shares of Zynex subject to Rule 16b-3
09/06/2024
3
Disposition of 185 shares by Anna Lucsok of Zynex at 8.41 subject to Rule 16b-3
09/09/2024
4
Disposition of 15000 shares by Daniel Moorhead of Zynex at 8.24 subject to Rule 16b-3
09/13/2024
5
Zynex Releases Q4 Earnings Guidance
10/24/2024
6
Disposition of 2323 shares by Anna Lucsok of Zynex at 9.12 subject to Rule 16b-3
10/25/2024
7
Acquisition by Anna Lucsok of 2764 shares of Zynex subject to Rule 16b-3
10/29/2024
8
Disposition of 2000 shares by Thomas Sandgaard of Zynex at 8.92 subject to Rule 16b-3
10/30/2024
9
Disposition of 2000 shares by Thomas Sandgaard of Zynex at 8.82 subject to Rule 16b-3
10/31/2024
10
Zynex CEO Thomas Sandgaard sells 52,740 in stock
11/01/2024
11
Insider Selling Zynex, Inc. CEO Sells 2,000 Shares of Stock
11/04/2024
12
Insider Sale CFO Daniel Moorhead Sells 10,000 Shares of Zynex Inc
11/05/2024
13
Zynex CEO Thomas Sandgaard sells shares worth 51,080
11/07/2024
14
Disposition of 2000 shares by Thomas Sandgaard of Zynex at 9.09 subject to Rule 16b-3
11/11/2024
15
Zynexs Returns On Capital Not Reflecting Well On The Business
11/12/2024
16
Disposition of 2000 shares by Thomas Sandgaard of Zynex at 8.09 subject to Rule 16b-3
11/14/2024
17
Zynex, Inc. CEO Sells 18,180.00 in Stock
11/15/2024
18
Disposition of 2000 shares by Thomas Sandgaard of Zynex at 8.67 subject to Rule 16b-3
11/21/2024

Complementary Tools for Zynex Stock analysis

When running Zynex's price analysis, check to measure Zynex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zynex is operating at the current time. Most of Zynex's value examination focuses on studying past and present price action to predict the probability of Zynex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zynex's price. Additionally, you may evaluate how the addition of Zynex to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Stocks Directory
Find actively traded stocks across global markets
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets